Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novartis Ag ADR
(NY:
NVS
)
102.10
+1.89 (+1.89%)
Official Closing Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novartis Ag ADR
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
38
39
Next >
Got $5,000? These 2 Stocks Are Bargain Buys Right Now
October 06, 2022
Whether you're looking for dividends or growth, Novartis and Paramount Global could be viable options for you.
Via
The Motley Fool
Novartis Whale Trades Spotted
September 28, 2022
A whale with a lot of money to spend has taken a noticeably bullish stance on Novartis. Looking at options history for Novartis (NYSE:NVS) we detected 21 strange trades.
Via
Benzinga
European Drug Makers Say Higher Energy Costs Eating Margins: Report
September 27, 2022
Europe's drug makers have warned about stopping manufacturing some cheap generic medicines amid surging electricity costs.
Via
Benzinga
Strength Seen in Lilly (LLY): Can Its 4.9% Jump Turn into More Strength?
September 23, 2022
Eli Lilly (LLY) shares rallied 4.9% in the last trading session to close at $310.87. This move can be attributable to notable volume with a higher number of shares being traded than in a typical...
Via
Talk Markets
Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test
September 23, 2022
Though successful in early testing, it wasn't enough to win a Phase 3 study.
Via
Investor's Business Daily
Citius Pharma Inks Clinical Collaboration For I/ONTAK Combo Regime in Solid Tumor Settings
September 23, 2022
Via
Benzinga
Novartis Unveils New Strategy Focused On US-First, Eight Blockbuster Brands
September 22, 2022
Via
Benzinga
Novartis' Cosentyx Shows To Ease Symptoms In Painful Skin Condition
September 12, 2022
Via
Benzinga
Novartis Injects $300M In Early-Stage Biologics Research Tech
September 12, 2022
Via
Benzinga
Top Financial Media Stories Thursday, September 22: Facebook Sued For Bypassing Apple Privacy Rules, Walmart Slows Hiring Plans Ahead Of Holiday Season, China Blames US For Northwestern Polytechnical University Hack And More..
September 22, 2022
Reuters
Via
Benzinga
7 Safe Havens All Investors Should Have Exposure to in 2022
September 22, 2022
Few stocks with deep value and growth prospects offer upside and safe havens for investors, with those picks the exception.
Via
InvestorPlace
Top Financial Media Stories Wednesday, September 21: Amazon's Roomba Maker Acquisition Attracts Regulatory Attention, Binance And FTX Bid For Voyager Digital's Assets, Germany Nationalizes Gas Giant Uniper To Avert Energy Crisis And More..
September 21, 2022
Wall Street Journal
Via
Benzinga
Novartis' Kisqali Adds One More Year Of Survival Benefit In Breast Cancer Setting
September 09, 2022
Via
Benzinga
VideoKrtoon Offers State Of The Art 2D Animation Services
September 07, 2022
Via
Prodigy
Novartis To Petition US Supreme Court To Uphold Patent Validity For Multiple Sclerosis Drug, Gilenya
September 21, 2022
Via
Benzinga
3 Stocks That Could Rocket on Biden’s Cancer Moonshot
September 20, 2022
Joe Biden’s cancer moonshot gave some of the drug companies a big shot in the arm. These three stocks all are doing big things in oncology.
Via
InvestorPlace
Vasculitis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Novartis, Ambulero, InflaRx
September 19, 2022
Continue reading "Vasculitis Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examines DelveInsight | Key Companies – Novartis, Ambulero, InflaRx"
Via
Get News
5 Value Stocks In The Healthcare Sector
September 19, 2022
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...
Via
Benzinga
Top Financial Media Stories Thursday, September 15: US Railway Companies, Unions Reach Tentative Agreement, Tesla To Wind Down Stores In China's Flashy Malls, Netflix Could Face Legal Action Over South Korean Crime Drama And More..
September 15, 2022
US Railway Companies, Unions Reach Tentative Agreement Averting Catastrophic Strike
Via
Benzinga
Swiss Competition Commission Investigates Novartis' Patent Use To Fend Off Competition
September 15, 2022
The Swiss competition commission (COMCO) has initiated an investigation against Novartis AG (NYSE: NVS) over the alleged unlawful patent use to reduce competitive pressure.
Via
Benzinga
Novartis Dodges Whistleblower Lawsuit Regarding Multiple Sclerosis Drug Kickback Claims
September 14, 2022
A federal judge dismissed a whistleblower lawsuit accusing Novartis AG (NYSE: NVS) of paying doctors kickbacks at "sham" speaker programs to boost prescriptions of its multiple sclerosis blockbuster...
Via
Benzinga
A Major October Catalyst Could Make This Eye Stock A Ten Bagger, Analyst Says
September 13, 2022
Chardan initiated coverage on Outlook Therapeutics Inc (NASDAQ: OTLK) with a Buy rati
Via
Benzinga
5 Value Stocks In The Healthcare Sector
September 12, 2022
What are Value Stocks?
Via
Benzinga
Smart Manufacturing Market Share 2022 Size, Key Trends, Future Scope, Global Outlook, Investment Plans and Development Status by 2027
September 09, 2022
Smart Manufacturing Market 2022 | Major Key Players included in this Report are Pfizer , Novartis, Abbott Laboratories and Many More with SWOT Analysis by 2027
Via
SBWire
No Early Relief for JW Therapeutics from Cancer Wonder Drug
September 07, 2022
Key Takeaways: JW Therapeutics prices its new cancer therapy at around a million yuan, with the high production costs hard to bring down. Large-scale market expansion is not going to be easy The...
Via
Benzinga
Appointment of Sachin Nanavati to PreveCeutical's Board of Directors
September 06, 2022
Vancouver, British Columbia--(Newsfile Corp. - September 6, 2022) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"...
Via
Newsfile
SiO2 Materials Science Names Yves Steffen as Chief Executive Officer
September 01, 2022
SiO2 Materials Science today announced the Board of Directors has appointed Yves Steffen as CEO effective Aug. 1, 2022.
Via
Newswire.com
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
September 01, 2022
Wall Street Journal
Via
Benzinga
Novartis Appoints Merck Executive As Research Head
September 01, 2022
Via
Benzinga
NYSE:NVS Investor Alert: Investigation over Potential Wrongdoing at Novartis AG
August 30, 2022
San Diego, CA -- (SBWIRE) -- 08/30/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Novartis AG.
Via
SBWire
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.